Close Window

Digital Look Email A Friend

Novo Nordisk to pay up to $2.6bn for rights to Hengrui Pharma weight-loss drug

Published by Michele Maatouk on 29th September 2026

(Sharecast News) - Novo Nordisk said on Tuesday that it has agreed to buy the rights to a Hengrui Pharma weight-loss drug for up to $2.6bn.

URL: http://www.digitallook.com/dl/news/story/36243265/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.